Edla, David Raj, et al. “Spesolimab: A Novel Interleukin-36 Receptor Monoclonal Antibody for the Treatment of Generalized Pustular Psoriasis”. Asian Journal of Pharmaceutical Research and Development, vol. 12, no. 3, June 2024, pp. 88-93, doi:10.22270/ajprd.v11i3.1400.